Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥20.2bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥36.2bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥18.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥2.5bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥2.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥1.7bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥2.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥84.4bnat 2024-09-30Cons.Assets
Total assets¥81.8bnat 2024-03-31Cons.Assets
Total assets¥79.6bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥9.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥9.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥75.3bnat 2024-09-30Cons.Net assets
Net assets / equity¥72.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥71.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥16.9bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥19.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥25.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥513m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥490m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥7.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥732m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥731m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.392024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.082023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.542023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio89.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2024-04-01 → 2024-09-30¥481m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥20.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥20.2bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.5bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2023-04-01 → 2023-09-30¥420m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-09-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Non operating expensesPrior1YTDDuration35000000JPY
Non operating expensesCurrentYTDDuration516000000JPY
Ordinary incomePrior1YTDDuration2327000000JPY
Ordinary incomeCurrentYTDDuration2354000000JPY
Income before income taxesPrior1YTDDuration2327000000JPY
Income before income taxesCurrentYTDDuration2354000000JPY
Income taxes currentPrior1YTDDuration249000000JPY
Income taxes currentCurrentYTDDuration305000000JPY
Income taxes deferredPrior1YTDDuration-24000000JPY
Income taxes deferredCurrentYTDDuration117000000JPY
Income taxesPrior1YTDDuration224000000JPY
Income taxesCurrentYTDDuration422000000JPY
Profit lossPrior1YTDDuration2102000000JPY
Profit lossCurrentYTDDuration1931000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration2102000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1931000000JPY
Profit lossPrior1YTDDuration2102000000JPY
Profit lossCurrentYTDDuration1931000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1346000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-234000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration14000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration1605000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration2081000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-46000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-75000000JPY
Other comprehensive incomePrior1YTDDuration2919000000JPY
Other comprehensive incomeCurrentYTDDuration1770000000JPY
Comprehensive incomePrior1YTDDuration5021000000JPY
Comprehensive incomeCurrentYTDDuration3701000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration5021000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3701000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration2327000000JPY
Income before income taxesCurrentYTDDuration2354000000JPY
Depreciation and amortization ope cfPrior1YTDDuration684000000JPY
Depreciation and amortization ope cfCurrentYTDDuration870000000JPY
Amortization of goodwill ope cfPrior1YTDDuration87000000JPY
Amortization of goodwill ope cfCurrentYTDDuration97000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration37000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration78000000JPY
Increase decrease in net defined benefit asset or liability ope cfPrior1YTDDuration-33000000JPY
Increase decrease in net defined benefit asset or liability ope cfCurrentYTDDuration-119000000JPY
Interest and dividends income ope cfPrior1YTDDuration-267000000JPY
Interest and dividends income ope cfCurrentYTDDuration-304000000JPY
Interest expenses ope cfPrior1YTDDuration2000000JPY
Interest expenses ope cfCurrentYTDDuration2000000JPY
Business structure improvement expenses ope cfPrior1YTDDuration29000000JPY
Business structure improvement expenses ope cfCurrentYTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass